Epilepsy Personal Assistant Device-A Mobile Platform for Brain State, Dense Behavioral and Physiology Tracking and Controlling Adaptive Stimulation

. 2021 ; 12 () : 704170. [epub] 20210729

Status PubMed-not-MEDLINE Jazyk angličtina Země Švýcarsko Médium electronic-ecollection

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid34393981

Grantová podpora
R01 NS092882 NINDS NIH HHS - United States
UH3 NS095495 NINDS NIH HHS - United States
UH3 NS112826 NINDS NIH HHS - United States

Epilepsy is one of the most common neurological disorders, and it affects almost 1% of the population worldwide. Many people living with epilepsy continue to have seizures despite anti-epileptic medication therapy, surgical treatments, and neuromodulation therapy. The unpredictability of seizures is one of the most disabling aspects of epilepsy. Furthermore, epilepsy is associated with sleep, cognitive, and psychiatric comorbidities, which significantly impact the quality of life. Seizure predictions could potentially be used to adjust neuromodulation therapy to prevent the onset of a seizure and empower patients to avoid sensitive activities during high-risk periods. Long-term objective data is needed to provide a clearer view of brain electrical activity and an objective measure of the efficacy of therapeutic measures for optimal epilepsy care. While neuromodulation devices offer the potential for acquiring long-term data, available devices provide very little information regarding brain activity and therapy effectiveness. Also, seizure diaries kept by patients or caregivers are subjective and have been shown to be unreliable, in particular for patients with memory-impairing seizures. This paper describes the design, architecture, and development of the Mayo Epilepsy Personal Assistant Device (EPAD). The EPAD has bi-directional connectivity to the implanted investigational Medtronic Summit RC+STM device to implement intracranial EEG and physiological monitoring, processing, and control of the overall system and wearable devices streaming physiological time-series signals. In order to mitigate risk and comply with regulatory requirements, we developed a Quality Management System (QMS) to define the development process of the EPAD system, including Risk Analysis, Verification, Validation, and protocol mitigations. Extensive verification and validation testing were performed on thirteen canines and benchtop systems. The system is now under a first-in-human trial as part of the US FDA Investigational Device Exemption given in 2018 to study modulated responsive and predictive stimulation using the Mayo EPAD system and investigational Medtronic Summit RC+STM in ten patients with non-resectable dominant or bilateral mesial temporal lobe epilepsy. The EPAD system coupled with an implanted device capable of EEG telemetry represents a next-generation solution to optimizing neuromodulation therapy.

Zobrazit více v PubMed

Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia. (1993) 34:453–68. 10.1111/j.1528-1157.1993.tb02586.x PubMed DOI

Christensen J, Vestergaard M, Pedersen MG, Pedersen CB, Olsen J, Sidenius P. Incidence and prevalence of epilepsy in Denmark. Epilepsy Res. (2007) 76:60–5. 10.1016/j.eplepsyres.2007.06.012 PubMed DOI

Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. (2000) 342:314–9. 10.1056/NEJM200002033420503 PubMed DOI

Camfield P, Camfield C. Idiopathic generalized epilepsy with generalized tonic-clonic seizures (IGE-GTC): a population-based cohort with >20 year follow up for medical and social outcome. Epilepsy Behav. (2010) 18:61–3. 10.1016/j.yebeh.2010.02.014 PubMed DOI

Salanova V, Witt T, Worth R, Henry TR, Gross RE, Nazzaro JM, et al. . Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy. Neurology. (2015) 84:1017–25. 10.1212/WNL.0000000000001334 PubMed DOI PMC

Nair DR, Laxer KD, Weber PB, Murro AM, Park YD, Barkley GL, et al. . Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy. Neurology. (2020) 95:e1244–56. 10.1212/WNL.0000000000010154 PubMed DOI PMC

Dumpelmann M. Early seizure detection for closed loop direct neurostimulation devices in epilepsy. J Neural Eng. (2019) 16:041001. 10.1088/1741-2552/ab094a PubMed DOI

Hoppe C, Poepel A, Elger CE. Epilepsy: accuracy of patient seizure counts. Archiv Neurol. (2007) 64:1595–9. 10.1001/archneur.64.11.1595 PubMed DOI

Baud MO, Kleen JK, Mirro EA, Andrechak JC, King-Stephens D, Chang EF, et al. . Multi-day rhythms modulate seizure risk in epilepsy. Nat Commun. (2018) 9:88. 10.1038/s41467-017-02577-y PubMed DOI PMC

Gregg NM, Nasseri M, Kremen V, Patterson EE, Sturges BK, Denison TJ, et al. . Circadian and multiday seizure periodicities, and seizure clusters in canine epilepsy. Brain communications. (2020) 2:fcaa008. 10.1093/braincomms/fcaa008 PubMed DOI PMC

Kuhlmann L, Lehnertz K, Richardson MP, Schelter B, Zaveri HP. Seizure prediction - ready for a new era. Nat Rev Neurol. (2018) 14:618–30. 10.1038/s41582-018-0055-2 PubMed DOI

Mormann F, Andrzejak RG, Elger CE, Lehnertz K. Seizure prediction: the long and winding road. Brain. (2007) 130(Pt 2):314–33. 10.1093/brain/awl241 PubMed DOI

Cook MJ, O'Brien TJ, Berkovic SF, Murphy M, Morokoff A, Fabinyi G, et al. . Prediction of seizure likelihood with a long-term, implanted seizure advisory system in patients with drug-resistant epilepsy: a first-in-man study. Lancet Neurol. (2013) 12:563–71. 10.1016/S1474-4422(13)70075-9 PubMed DOI

Brinkmann BH, Patterson EE, Vite C, Vasoli VM, Crepeau D, Stead M, et al. . Forecasting seizures using intracranial EEG measures and SVM in naturally occurring canine epilepsy. PLoS ONE. (2015) 10:e0133900. 10.1371/journal.pone.0133900 PubMed DOI PMC

Davis SF, Altstadt T, Flores R, Kaye A, Oremus G. Report of seizure following intraoperative monitoring of transcranial motor evoked potentials. Ochsner J. (2013) 13:558–60. PubMed PMC

Stanslaski S, Herron J, Chouinard T, Bourget D, Isaacson B, Kremen V, et al. . A chronically implantable neural coprocessor for investigating the treatment of neurological disorders. IEEE Trans Biomed Circuits Syst. (2018) 12:1230–45. 10.1109/TBCAS.2018.2880148 PubMed DOI PMC

Carroll N, Richardson I. Software-as-a-medical device: demystifying connected health regulations. J Syst Inform Technol. (2016) 18:186–215. 10.1108/JSIT-07-2015-0061 DOI

Yaeger KA, Martini M, Yaniv G, Oermann EK, Costa AB. United States regulatory approval of medical devices and software applications enhanced by artificial intelligence. Health Policy Technol. (2019) 8:192–7. 10.1016/j.hlpt.2019.05.006 DOI

Butler D. Translational research: crossing the valley of death. Nat News. (2008) 453:840–2. 10.1038/453840a PubMed DOI

Forsberg K, Mooz H. The relationship of system engineering to the project cycle. In: INCOSE International Symposium. Chattanooga, TN: Wiley Online Library; (1991). 10.1002/j.2334-5837.1991.tb01484.x DOI

Brinkmann BH, Bower MR, Stengel KA, Worrell GA, Stead M. Large-scale electrophysiology: acquisition, compression, encryption, and storage of big data. J Neurosci Methods. (2009) 180:185–92. 10.1016/j.jneumeth.2009.03.022 PubMed DOI PMC

Bower MR, Stead M, Bower RS, Kucewicz MT, Sulc V, Cimbalnik J, et al. . Evidence for consolidation of neuronal assemblies after seizures in humans. J Neurosci. (2015) 35:999–1010. 10.1523/JNEUROSCI.3019-14.2015 PubMed DOI PMC

Nahum M, Van Vleet TM, Sohal VS, Mirzabekov JJ, Rao VR, Wallace DL, et al. . Immediate Mood Scaler: tracking symptoms of depression and anxiety using a novel mobile mood scale. JMIR mHealth uHealth. (2017) 5:e44. 10.2196/mhealth.6544 PubMed DOI PMC

Haut SR, Hall CB, Borkowski T, Tennen H, Lipton RB. Clinical features of the pre-ictal state: mood changes and premonitory symptoms. Epilepsy Behav. (2012) 23:415–21. 10.1016/j.yebeh.2012.02.007 PubMed DOI

Karoly PJ, Freestone DR, Boston R, Grayden DB, Himes D, Leyde K, et al. . Interictal spikes and epileptic seizures: their relationship and underlying rhythmicity. Brain. (2016) 139:1066–78. 10.1093/brain/aww019 PubMed DOI

Baldassano SN, Brinkmann BH, Ung H, Blevins T, Conrad EC, Leyde K, et al. . Crowdsourcing seizure detection: algorithm development and validation on human implanted device recordings. Brain. (2017) 140:1680–91. 10.1093/brain/awx098 PubMed DOI PMC

Brinkmann BH, Wagenaar J, Abbot D, Adkins P, Bosshard SC, Chen M, et al. . Crowdsourcing reproducible seizure forecasting in human and canine epilepsy. Brain. (2016) 139(Pt 6):1713–22. 10.1093/brain/aww045 PubMed DOI PMC

Nasseri M, Kremen V, Nejedly P, Kim I, Chang SY, Jo HJ, et al. . Semi-supervised training data selection improves seizure forecasting in canines with epilepsy. Biomed Signal Proc Control. (2020) 57:101743. 10.1016/j.bspc.2019.101743 PubMed DOI PMC

Kremen V, Brinkmann BH, Kim I, Guragain H, Nasseri M, Magee AL, et al. . Integrating brain implants with local and distributed computing devices: a next generation epilepsy management system. IEEE J Transl Eng Health Med. (2018) 6:2500112. 10.1109/JTEHM.2018.2869398 PubMed DOI PMC

Sladky V, Nejedly P, Mivalt F, Brinkmann BH, Kim I, Louis EKS, et al. . Distributed brain co-processor for neurophysiologic tracking and adaptive stimulation: application to drug resistant epilepsy. bioRxiv [Preprint]. (2021). 10.1101/2021.03.08.434476 DOI

Toth R, Zamora M, Ottaway J, Gillbe T, Martin S, Benjaber M, et al. . DyNeuMo Mk-2: an investigational circadian-locked neuromodulator with responsive stimulation for applied chronobiology. Conf Proc IEEE Int Conf Syst Man Cyber. (2020) 2020:3433–440. 10.1109/SMC42975.2020.9283187 PubMed DOI PMC

Nasseri M, Nurse E, Glasstetter M, Böttcher S, Gregg NM, Laks Nandakumar A, et al. . Signal quality and patient experience with wearable devices for epilepsy management. Epilepsia. (2020) 61:S25–35. 10.1111/epi.16527 PubMed DOI

Biondi, Laiou P, Bruno E, Viana PF, Schreuder M, Hart W, Nurse E, et al. . Remote and long-term self-monitoring of electroencephalographic and noninvasive measurable variables at home in patients with epilepsy (EEG@ HOME): protocol for an observational study. JMIR Res Protocols. (2021) 10:e25309. 10.2196/25309 PubMed DOI PMC

Viana PF, Duun-Henriksen J, Glasstëter M, Dümpelmann M, Nurse ES, Martins IP, et al. . 230 days of ultra long-term subcutaneous EEG: seizure cycle analysis and comparison to patient diary. Ann Clin Transl Neurol. (2021) 8:288–93. 10.1002/acn3.51261 PubMed DOI PMC

Elger CE, Hoppe C. Diagnostic challenges in epilepsy: seizure under-reporting and seizure detection. Lancet Neurol. (2018) 17:279–88. 10.1016/S1474-4422(18)30038-3 PubMed DOI

Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, Jansen FE, et al. . Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia. (2017) 58:522–30. 10.1111/epi.13670 PubMed DOI

Nejedly P, Kremen V, Sladky V, Nasseri M, Guragain H, Klimes P, et al. . Deep-learning for seizure forecasting in canines with epilepsy. J Neural Eng. (2019) 16:036031. 10.1088/1741-2552/ab172d PubMed DOI

Salpekar JA, Mula M. Common psychiatric comorbidities in epilepsy: how big of a problem is it? Epilepsy Behav. (2019) 98:293–7. 10.1016/j.yebeh.2018.07.023 PubMed DOI

Helmstaedter C, Witt JA. Epilepsy and cognition–a bidirectional relationship? Seizure. (2017) 49:83–9. 10.1016/j.seizure.2017.02.017 PubMed DOI

Haut SR, Gursky JM, Privitera M. Behavioral interventions in epilepsy. Curr Opin Neurol. (2019) 32:227–36. 10.1097/WCO.0000000000000661 PubMed DOI

Karoly PJ, Goldenholz DM, Freestone DR, Moss RE, Grayden DB, Theodore WH, et al. . Circadian and circaseptan rhythms in human epilepsy: a retrospective cohort study. Lancet Neurol. (2018) 17:977–85. 10.1016/S1474-4422(18)30274-6 PubMed DOI

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...